ES
Ekkehard Schutz
Chief Science OfficerProf. Dr. Ekkehard Sch?tz, M.D., Ph.D., FAACC, also known as Ekke, serves as Chief Science Officer at Insight Molecular Diagnostics Inc. (formerly known as OncoCyte Corporation) since 2023 and was its Chief Technology Officer since 2022 until 2023. He serves as the Chief Technology Officer at Chronix Biomedical, Inc. He served as Vice President of Research at Chronix Biomedical, Inc. He joined Chronix in 2000 and has done past work in medical laboratory diagnostics. Dr. Sch?tz has over 110 peer reviewed publications and several awards. He is a highly cited and recognized expert in the field of Genetics. He received his M.D. and Ph.D. in Molecular Diagnostics from the University of G?ttingen.
Positions
- Company NameInsight Molecular Diagnostics Inc.Stock CodeIMDXPositionChief Science OfficerColleagues
- JRJoshua RiggsPresident, CEO & Director
- AAAndrew ArnoIndependent Chairman
- ASAndrea Susan JamesChief Financial Officer
- JLJames LiuVP of Accounting, Treasurer, Controller & Principal Accounting Officer
- YCYuh-Min ChiangChief Technology Officer
- AJAndrew J. LastIndependent Director
- LELouis E. SilvermanIndependent Director
- DRDavid R. GandaraMember of Scientific & Medical Advisory Board
